Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard Post History

by Eoganacht


V.TLT

RE:Hope and Caution. Of IQs and EQs

You are either being disingenuous or you haven't been around long enough....

February 7, 2023

V.TLT

RE:RE:RE:RE:RE:Potential Rise

As a thought experiment, if we assume 12 of the 14 questionable patients were...

February 6, 2023

V.TLT

RE:RE:RE:Potential Rise

Hi consultant99 - with all of the BCG-unresponsive NMIBC treatments we have...

February 6, 2023

V.TLT

The Implications of TLD1433 PDT Approval for NMIBC Patients

It looks like the best option for BCG-unresponsive NMIBC patients right now...

January 27, 2023

V.TLT

RE:RE:FDA Approval for TLD1433 pdt almost certain IMHO

Hi Kingpin - this was a trial for high risk NMIBC which would presumably mean...

January 26, 2023

V.TLT

FDA Approval for TLD1433 pdt almost certain IMHO

In December 2022 Ferring received FDA approval for Adstiladrin for high...

January 26, 2023

V.TLT

RE:RE:RE:RE:RE:Excellent news! Out first official exposure to ASCO world

There's also the 78th Annual Meeting of the Canadian Urological...

January 25, 2023

V.TLT

RE:Pfizer or Roche as jv partners for the NMIBC

If we look at the 3 companies, Pfizer is biggest, with 2022 pharmaceutical...

January 24, 2023

V.TLT

RE:Theralase & Merck

Merck also makes BCG, the first line treatment for intermediate to high risk...

January 24, 2023

V.TLT

RE:RE:RE:RE:RE:RE:RE:RE:Accelerated Approval ahead of AUA congress would spark

Right. It's never been explained why Roswell Park chose photofrin over...

January 20, 2023

V.TLT

RE:RE:RE:RE:RE:RE:Accelerated Approval ahead of AUA congress would spark

Hi Rumple - Roswell Park is already treating 3 types of skin cancer with pdt...

January 19, 2023

V.TLT

RE:RE:RE:RE:Accelerated Approval ahead of AUA congress would spark

I don't think pdt is used for melanoma yet although it is used for other...

January 19, 2023

V.TLT

RE:Accelerated Approval ahead of AUA congress would spark

ScienceFirst wrote: "Accelerated Approval, instead of Breakthrough...

January 18, 2023

V.TLT

RE:RE:Note the insider buying chart last 6 months !

It helps to while away the weary hours of waiting :) FGPstock wrote...

January 18, 2023

V.TLT

New Paper by Dr. Lilge

Dr. Lilge and colleagues continue to work on fine-tuning light delivery...

January 16, 2023

V.TLT

RE:RE:FDA to rule on BLA for N-803 + BCG for NMIBC by May 23, 2023

Good post, CancerSlayer. CancerSlayer wrote: Eoganacht wrote: If the FDA...

January 15, 2023

V.TLT

RE:FDA to rule on BLA for N-803 + BCG for NMIBC by May 23, 2023

In my last post whenever I write Cohort B I mean Cohort C. Sorry for the...

January 15, 2023

V.TLT

FDA to rule on BLA for N-803 + BCG for NMIBC by May 23, 2023

If the FDA rules favourably for ImmunityBio's BLA in May what will this...

January 15, 2023

V.TLT

RE:RE:RE:RE:RE:RE:RE:Feature article about Theralase on biotuesdays.com website

There was a simulation study conducted by Drs. Wettstein, Naimark, Hermanns,&...

January 9, 2023

V.TLT

RE:RE:RE:Feature article about Theralase on biotuesdays.com website

Our current trial is for high risk BCG unresponsive NMIBC. The percentage of...

January 9, 2023

Featured Company